Some strains of Neisseria gonorrhoeae, the bacteria that causes the sexually transmitted infection (STI) gonorrhea, have ...

EAGLE-1 trial data shows gepotidacin’s potential in treating gonorrhoea, for which no new antibiotics have been approved ...

For uncomplicated urogenital gonorrhea, gepotidacin, which inhibits bacterial DNA replication, is noninferior to ceftriaxone ...

In a clinical trial, the UTI drug gepotidacin cleared infections in 93% of cases, performing just as well as the current ...

The only lab in the U.S. capable of testing for and tracking antibiotic-resistant gonorrhea, or “super gonorrhea,” was ...

Gepotidacin is a new oral antibacterial treatment with the potential to become an alternative option for treating infections.

The appendix is thought to play a role in all of this by producing inflammatory proteins that trigger the body to produce ...

Alaska is seeing a dangerous gonorrhea outbreak, while the CDC's STD lab and field staff have been cut. What happens to sexual health when states lose their first line of defense?

A novel antibiotic recently approved for treatment of urinary tract infections also shows efficacy against gonorrhea, ...

An antibiotic that is commonly used for urinary tract infections effectively treated gonorrhoea, and may even work against ...

This innovative oral antibacterial treatment poses a promising defense against the increasingly drug-resistant strains of Neisseria gonorrhoeae, the bacterium responsible for the infection.